0001209191-20-012285.txt : 20200224 0001209191-20-012285.hdr.sgml : 20200224 20200224200214 ACCESSION NUMBER: 0001209191-20-012285 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200216 FILED AS OF DATE: 20200224 DATE AS OF CHANGE: 20200224 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BRYANT DOUGLAS C CENTRAL INDEX KEY: 0001406652 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-10961 FILM NUMBER: 20646820 MAIL ADDRESS: STREET 1: C/O QUIDEL CORPORATION STREET 2: 12544 HIGH BLUFF DRIVE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUIDEL CORP /DE/ CENTRAL INDEX KEY: 0000353569 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 942573850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9975 SUMMERS RIDGE ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8585521100 MAIL ADDRESS: STREET 1: 9975 SUMMERS RIDGE ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/ DATE OF NAME CHANGE: 19910210 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2020-02-16 2020-02-19 0 0000353569 QUIDEL CORP /DE/ QDEL 0001406652 BRYANT DOUGLAS C 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 1 1 0 0 President & CEO Common Stock 2020-02-16 4 F 0 8198 80.40 D 440823 D On February 19, 2020, the Reporting Person filed a Form 4 which reported the disposition of 8,606 shares in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon the release of restricted stock units. Due to a clerical error, the number of shares reported as withheld was incorrectly calculated and reported. The correct amount of shares withheld was 8,198. Robert J. Bujarski, attorney-in-fact for Douglas C. Bryant 2020-02-24